I’ve been tracking the evolving guidance on Ivermectin in the U.S. this year, and August 2025 brought a new wave of confusion. While some general practitioners support its continued off-label use, medical associations remain split.
👉 Here’s the article I’m referencing: Mixed Messaging on Ivermectin – August 2025
Curious if others here have noticed the same contradictory narratives. How is this affecting patient trust where you are?
Let’s discuss — especially if you’ve seen regional differences or new research emerge!
Asked by: swanben100 on Aug. 4, 2025, 12:29 p.m. Last updated on Aug. 4, 2025, 12:29 p.m.